cMyc inhibitors (MecRx/CSIRO)

N/A

Report date: 2025/01/26 16:41:37
NME

Base Information

Drug NamecMyc inhibitors (MecRx/CSIRO)
Drug Alias Nameoncoprotein Myc inhibitors (MecRx/CSIRO)MRX-1669
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyc proto-oncogene protein inhibitors
TargetsMyc proto-oncogene protein
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMecRX Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A